{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:58:30Z","timestamp":1781074710459,"version":"3.54.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00228-026-04071-1","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T01:04:54Z","timestamp":1778547894000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of loop diuretics for chronic heart failure: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"82","author":[{"given":"Sami","family":"Taleghani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilie C.","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin Dam","family":"Lukoschewitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida Arentz","family":"Taraldsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Tonning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"El-Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik Dencker","family":"Wisborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Vishram-Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Frydland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janus C.","family":"Jakobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Dahlgaard","family":"Hove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Grand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"4071_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab368","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Baumbach A, B\u00f6hm M, Burri H et al (2021) 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. https:\/\/doi.org\/10.1093\/eurheartj\/ehab368","journal-title":"Eur Heart J"},{"key":"4071_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.14255","author":"AH Behnoush","year":"2023","unstructured":"Behnoush AH, Khalaji A, Naderi N, Ashraf H, von Haehling S (2023) ACC\/AHA\/HFSA 2022 and ESC 2021 guidelines on heart failure comparison. ESC Heart Fail. https:\/\/doi.org\/10.1002\/ehf2.14255","journal-title":"ESC Heart Fail"},{"key":"4071_CR3","doi-asserted-by":"publisher","unstructured":"Mentz RJ, Anstrom KJ, Eisenstein EL, Sapp S, Greene SJ, Morgan S et al (2023) Effect of torsemide vs furosemide after discharge on all-cause mortality in patients hospitalized with heart failure: The TRANSFORM-HF randomized clinical trial. JAMA 329(3). https:\/\/doi.org\/10.1001\/jama.2022.23924","DOI":"10.1001\/jama.2022.23924"},{"key":"4071_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2014.12.009","author":"J Buggey","year":"2015","unstructured":"Buggey J, Mentz RJ, Pitt B, Eisenstein EL, Anstrom KJ, Velazquez EJ et al (2015) A reappraisal of loop diuretic choice in heart failure patients. Am Heart J. https:\/\/doi.org\/10.1016\/j.ahj.2014.12.009","journal-title":"Am Heart J"},{"key":"4071_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s11897-024-00643-3","author":"JJ Cuthbert","year":"2024","unstructured":"Cuthbert JJ, Clark AL (2024) Diuretic Treatment in Patients with Heart Failure: Current Evidence and Future Directions \u2013 Part I: Loop Diuretics. Curr Heart Fail Rep. https:\/\/doi.org\/10.1007\/s11897-024-00643-3","journal-title":"Curr Heart Fail Rep"},{"key":"4071_CR6","doi-asserted-by":"crossref","unstructured":"Ellison DH, Felker GM (2017) Diuretic treatment in heart failure\u2013from physiology to clinical trials. N Engl J Med 377(20)","DOI":"10.1056\/NEJMra1703100"},{"key":"4071_CR7","doi-asserted-by":"publisher","unstructured":"Mullens W, Damman K, Harjola VP, Mebazaa A, Brunner-La Rocca HP, Martens P et al (2019) The use of diuretics in heart failure with congestion \u2014 a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 21(2). https:\/\/doi.org\/10.1002\/ejhf.1369","DOI":"10.1002\/ejhf.1369"},{"key":"4071_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000097","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Antes G, Atkins D et al (2009) Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. https:\/\/doi.org\/10.1371\/journal.pmed.1000097","journal-title":"PLoS Med"},{"key":"4071_CR9","unstructured":"The Copenhagen trial unit"},{"issue":"3","key":"4071_CR10","doi-asserted-by":"publisher","first-page":"e70005","DOI":"10.1111\/aas.70005","volume":"69","author":"S Taleghani","year":"2025","unstructured":"Taleghani S, Lukoschewitz JD, Tonning S, Taraldsen IA, Jakobsen JC, Grand J (2025) Comparison of all types of loop-diuretics for chronic heart failure: A protocol for a systematic review and network meta-analysis. Acta Anaesthesiol Scand 69(3):e70005. https:\/\/doi.org\/10.1111\/aas.70005","journal-title":"Acta Anaesthesiol Scand"},{"key":"4071_CR11","unstructured":"Covidence - Better systematic review management"},{"key":"4071_CR12","doi-asserted-by":"publisher","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366. https:\/\/doi.org\/10.1136\/bmj.l4898","DOI":"10.1136\/bmj.l4898"},{"key":"4071_CR13","doi-asserted-by":"publisher","unstructured":"Trippel TD, Van Linthout S, Westermann D, Lindhorst R, Sandek A, Ernst S et al (2018) Investigating a biomarker-driven approach to target collagen turnover in diabetic heart failure with preserved ejection fraction patients. Effect of torasemide versus furosemide on serum C-terminal propeptide of procollagen type I (DROP-PIP trial). Eur J Heart Fail 20(3). https:\/\/doi.org\/10.1002\/ejhf.960","DOI":"10.1002\/ejhf.960"},{"key":"4071_CR14","doi-asserted-by":"publisher","unstructured":"Okuhara Y, Asakura M, Orihara Y, Naito Y, Tsujino T, Ishihara M et al (2019) Effects of weight loss in outpatients with mild chronic heart failure: findings from the J-MELODIC study. J Card Fail 25(1). https:\/\/doi.org\/10.1016\/j.cardfail.2018.11.003","DOI":"10.1016\/j.cardfail.2018.11.003"},{"key":"4071_CR15","doi-asserted-by":"publisher","unstructured":"Miyata M, Sasaki T, Ikeda Y, Shinsato T, Kubozono T, Furusho Y et al (2012) Comparative study of therapeutic effects of short- and long-acting loop diuretics in outpatients with chronic heart failure (COLD-CHF). J Cardiol 59(3). https:\/\/doi.org\/10.1016\/j.jjcc.2011.12.007","DOI":"10.1016\/j.jjcc.2011.12.007"},{"key":"4071_CR16","doi-asserted-by":"publisher","unstructured":"Effects of prolonged- (2011) release torasemide versus furosemide on myocardial fibrosis in hypertensive patients with chronic heart failure: a randomized, blinded-end point, active-controlled study. Clin Ther 33(9). https:\/\/doi.org\/10.1016\/j.clinthera.2011.08.006","DOI":"10.1016\/j.clinthera.2011.08.006"},{"key":"4071_CR17","doi-asserted-by":"publisher","unstructured":"Kasama S, Toyama T, Hatori T, Sumino H, Kumakura H, Takayama Y et al (2006) Effects of torasemide on cardiac sympathetic nerve activity and left ventricular remodelling in patients with congestive heart failure. Heart 92(10). https:\/\/doi.org\/10.1136\/hrt.2005.079764","DOI":"10.1136\/hrt.2005.079764"},{"key":"4071_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.09.009","author":"T Tsutamoto","year":"2004","unstructured":"Tsutamoto T, Sakai H, Wada A, Ishikawa C, Ohno K, Fujii M et al (2004) Torasemide inhibits transcardiac extraction of aldosterone in patients with congestive heart failure [3]. J Am Coll Cardiol. https:\/\/doi.org\/10.1016\/j.jacc.2004.09.009","journal-title":"J Am Coll Cardiol"},{"key":"4071_CR19","doi-asserted-by":"publisher","unstructured":"L\u00f3pez B, Querejeta R, Gonz\u00e1lez A, S\u00e1nchez E, Larman M, D\u00edez J (2004) Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure. J Am Coll Cardiol 43(11). https:\/\/doi.org\/10.1016\/j.jacc.2003.12.052","DOI":"10.1016\/j.jacc.2003.12.052"},{"key":"4071_CR20","doi-asserted-by":"publisher","unstructured":"M\u00fcller K, Gamba G, Jaquet F, Hess B (2003) Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV - Efficacy and quality of life. Eur J Heart Fail 5(6). https:\/\/doi.org\/10.1016\/S1388-9842(03)00150-8","DOI":"10.1016\/S1388-9842(03)00150-8"},{"key":"4071_CR21","doi-asserted-by":"publisher","unstructured":"Noe LL, Vreeland MG, Pezzella SM, Trotter JP (1999) A pharmacoeconomic assessment of torsemide and furosemide in the treatment of patients with congestive heart failure. Clin Ther 21(5). https:\/\/doi.org\/10.1016\/S0149-2918(99)80007-1","DOI":"10.1016\/S0149-2918(99)80007-1"},{"key":"4071_CR22","doi-asserted-by":"publisher","unstructured":"Balsam P, Oziera\u0144ski K, Marchel M, Gawa\u0142ko M, Niedziela \u0141, Tymi\u0144ska A et al (2019) Comparative effectiveness of torasemide versus furosemide in symptomatic therapy in heart failure patients: Preliminary results from the randomized tornado trial. Cardiol J 26(6). https:\/\/doi.org\/10.5603\/CJ.a2019.0114","DOI":"10.5603\/CJ.a2019.0114"},{"key":"4071_CR23","doi-asserted-by":"publisher","unstructured":"Car N, Skrabalo Z, Verho M (1988) The effects of piretanide in patients with congestive heart failure and diabetes mellitus: a double-blind comparison with furosemide. Curr Med Res Opin 11(2). https:\/\/doi.org\/10.1185\/03007998809110456","DOI":"10.1185\/03007998809110456"},{"key":"4071_CR24","doi-asserted-by":"publisher","unstructured":"Ferrara N, Leosco D, Del Prete M, Lombardi L, Landino P, Abete P et al (1997) Torasemide versus furosemide in patients with congestive heart failure: a double-masked, randomized study. Curr Ther Res Clin Exp 58(5). https:\/\/doi.org\/10.1016\/S0011-393X(97)80026-4","DOI":"10.1016\/S0011-393X(97)80026-4"},{"key":"4071_CR25","unstructured":"Goebel KM (1993) Six-week study of torsemide in patients with congestive heart failure. Clin Ther. ;15(6)"},{"key":"4071_CR26","doi-asserted-by":"publisher","unstructured":"Gottlieb SS, Khatta M, Wentworth D, Roffman D, Fisher ML, Kramer WG (1998) The effects of diuresis on the pharmacokinetics of the loop diuretics furosemide and torsemide in patients with heart failure. Am J Med 104(6). https:\/\/doi.org\/10.1016\/S0002-9343(98)00111-9","DOI":"10.1016\/S0002-9343(98)00111-9"},{"key":"4071_CR27","doi-asserted-by":"publisher","unstructured":"Hariman RJ, Bremner S, Louie EK, Rogers WJ, Kostis JB, Nocero MA et al (1994) Dose-response study of intravenous torsemide in congestive heart failure. Am Heart J 128(2). https:\/\/doi.org\/10.1016\/0002-8703(94)90489-8","DOI":"10.1016\/0002-8703(94)90489-8"},{"key":"4071_CR28","doi-asserted-by":"publisher","unstructured":"Konecke LL (1981) Clinical trial of bumetanide versus furosemide in patients with congestive heart failure. J Clin Pharmacol 21(11). https:\/\/doi.org\/10.1002\/j.1552-4604.1981.tb05684.x","DOI":"10.1002\/j.1552-4604.1981.tb05684.x"},{"key":"4071_CR29","doi-asserted-by":"publisher","unstructured":"Marsh JD, Nesto R, Glynn M, ann, Smith TW (1982) Comparison of intravenous piretanide and furosemide in patients with congestive heart failure. J Cardiovasc Pharmacol 4(6). https:\/\/doi.org\/10.1097\/00005344-198211000-00011","DOI":"10.1097\/00005344-198211000-00011"},{"key":"4071_CR30","doi-asserted-by":"publisher","unstructured":"Murray MD, Deer MM, Ferguson JA, Dexter PR, Bennett SJ, Perkins SM et al (2001) Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure. Am J Med 111(7). https:\/\/doi.org\/10.1016\/S0002-9343(01)00903-2","DOI":"10.1016\/S0002-9343(01)00903-2"},{"key":"4071_CR31","doi-asserted-by":"publisher","unstructured":"Newton PJ, Davidson PM, Krum H, Ollerton R, Macdonald P (2012) The acute haemodynamic effect of nebulised frusemide in stable, advanced heart failure. Heart Lung Circ 21(5). https:\/\/doi.org\/10.1016\/j.hlc.2012.03.002","DOI":"10.1016\/j.hlc.2012.03.002"},{"key":"4071_CR32","doi-asserted-by":"publisher","unstructured":"Patterson JH, Adams KF, Applefeld MM, Corder CN, Masse BR (1994) Oral torsemide in patients with chronic congestive heart failure: effects on body weight, edema, and electrolyte excretion. Pharmacotherapy: J Hum Pharmacol Drug Therapy 14(5). https:\/\/doi.org\/10.1002\/j.1875-9114.1994.tb02848.x","DOI":"10.1002\/j.1875-9114.1994.tb02848.x"},{"key":"4071_CR33","doi-asserted-by":"publisher","unstructured":"Sherman LG, Liang C, seng, Baumgardner S, Charuzi Y, Chardo F, Kim CS (1986) Piretanide, a potent diuretic with potassium-sparing properties, for the treatment of congestive heart failure. Clin Pharmacol Ther 40(5). https:\/\/doi.org\/10.1038\/clpt.1986.228","DOI":"10.1038\/clpt.1986.228"},{"key":"4071_CR34","doi-asserted-by":"publisher","unstructured":"Stroupe KT, Forthofer MM, Brater DC, Murray MD (2000) Healthcare costs of patients with heart failure treated with torasemide or furosemide. PharmacoEconomics 17(5). https:\/\/doi.org\/10.2165\/00019053-200017050-00002","DOI":"10.2165\/00019053-200017050-00002"},{"key":"4071_CR35","doi-asserted-by":"publisher","unstructured":"T\u00e4ger T, Fr\u00f6hlich H, Seiz M, Katus HA, Frankenstein L (2019) READY: relative efficacy of loop diuretics in patients with chronic systolic heart failure\u2014a systematic review and network meta-analysis of randomised trials. Heart Fail Rev 24(4). https:\/\/doi.org\/10.1007\/s10741-019-09771-8","DOI":"10.1007\/s10741-019-09771-8"},{"key":"4071_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/clc.24088","author":"H Ahmad Cheema","year":"2024","unstructured":"Ahmad Cheema H, Azeem S, Ejaz A, Khan F, Muhammad A, Shahid A et al (2024) Efficacy and safety of torsemide versus furosemide in heart failure patients: A systematic review of randomized controlled trials. Clin Cardiol. https:\/\/doi.org\/10.1002\/clc.24088","journal-title":"Clin Cardiol"},{"key":"4071_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.12.059","author":"GM Felker","year":"2020","unstructured":"Felker GM, Ellison DH, Mullens W, Cox ZL, Testani JM (2020) Diuretic Therapy for Patients With Heart Failure: JACC State-of-the-Art Review. J Am Coll Cardiol. https:\/\/doi.org\/10.1016\/j.jacc.2019.12.059","journal-title":"J Am Coll Cardiol"},{"key":"4071_CR38","doi-asserted-by":"publisher","unstructured":"Nouhravesh N, Greene SJ, Clare R, Wojdyla D, Anstrom KJ, Velazquez E et al (2024) Diuretic dosing and outcomes with torsemide and furosemide following hospitalization for heart failure: The TRANSFORM-HF trial. Eur J Heart Fail 1. https:\/\/doi.org\/10.1002\/ejhf.3458","DOI":"10.1002\/ejhf.3458"},{"key":"4071_CR39","doi-asserted-by":"publisher","unstructured":"Terrovitis J, Kapelios C, Kaldara E, Ntalianis A, Sousonis V, Sfakianaki T et al (2013) High furosemide doses increase mortality and morbidity in stable chronic heart failure: A prospective, randomized study. J Am Coll Cardiol 61(10). https:\/\/doi.org\/10.1016\/s0735-1097(13)60765-2","DOI":"10.1016\/s0735-1097(13)60765-2"},{"key":"4071_CR40","doi-asserted-by":"crossref","unstructured":"Mohamed AE, Ramadan S, Afify R, Ellaban M, Ishak J, Shafiek FAM et al Torsemide versus furosemide in patients with heart failure: a systematic review and meta-analysis [Internet]. Available from: https:\/\/academic.oup.com\/eurheartj\/article\/45\/Supplement_1\/ehae666.3356\/7838972","DOI":"10.1093\/eurheartj\/ehae666.3356"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04071-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-026-04071-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04071-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:17:17Z","timestamp":1781072237000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-026-04071-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4071"],"URL":"https:\/\/doi.org\/10.1007\/s00228-026-04071-1","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"24 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1st author assigned affiliation update.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}],"article-number":"150"}}